Literature DB >> 7201438

Diurnal changes in serum unconjugated bile acids in normal man.

K D Setchell, A M Lawson, E J Blackstock, G M Murphy.   

Abstract

Unconjugated bile acids were measured using gas chromatography-mass spectrometry in the serum of two subjects throughout a 24 hour period and in two other subjects over a six hour period after breakfast. Unconjugated bile acids were found in all samples of serum and included cholic, chenodeoxycholic, deoxycholic, 3 beta, 7 alpha-dihydroxy-5 beta-cholanic (iso-chenodeoxycholic), ursodeoxycholic, 3 beta, 7 beta-dihydroxy-5 beta-cholanic (iso-ursodeoxycholic), 3 beta-hydroxy-5-cholenoic, and lithocholic acids. The maximum concentration of each bile acid generally occurred between breakfast and dinner and total unconjugated bile acid concentrations attained levels of between 2-3 mumol/l. Concentrations increased after breakfast and were often as high as 30-40% of the conjugated bile acid glycocholate, but returned to fasting levels in the absence of lunch. The intestinal absorption of unconjugated bile acids is therefore of greater quantitative importance than was previously thought.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201438      PMCID: PMC1419125          DOI: 10.1136/gut.23.8.637

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  Serum-bile-acids in the stagnant-loop syndrome.

Authors:  B Lewis; S Tabaqchali; D Panveliwalla; I D Wootton
Journal:  Lancet       Date:  1969-02-01       Impact factor: 79.321

2.  Postprandial serum bile acid for the detection of hepatobiliary disease.

Authors:  N Kaplowitz; E Kok; N B Javitt
Journal:  JAMA       Date:  1973-07-16       Impact factor: 56.272

3.  Mechanisms for the intestinal absorption of bile acids.

Authors:  J M Dietschy
Journal:  J Lipid Res       Date:  1968-05       Impact factor: 5.922

4.  Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases.

Authors:  I Makino; S Nakagawa; K Mashimo
Journal:  Gastroenterology       Date:  1969-06       Impact factor: 22.682

5.  Bile acid transformations by microbial strains belonging to genera found in intestinal contents.

Authors:  T Midtvedt; A Norman
Journal:  Acta Pathol Microbiol Scand       Date:  1967

6.  Bile acid inhibition of the intestinal microflora--a function for simple bile acids?

Authors:  M H Floch; W Gershengoren; S Elliott; H M Spiro
Journal:  Gastroenterology       Date:  1971-08       Impact factor: 22.682

7.  Bacterial modification of taurocholate during enterohepatic recirculation in normal man and patients with small intestinal disease.

Authors:  J T Garbutt; R M Wilkins; L Lack; M P Tyor
Journal:  Gastroenterology       Date:  1970-10       Impact factor: 22.682

8.  The influence of conjugation of cholic acid on its uptake and secretion: hepatic extraction of taurocholate and cholate in the dog.

Authors:  E R O'Máille; T G Richards; A H Short
Journal:  J Physiol       Date:  1967-04       Impact factor: 5.182

9.  Characterization of trisubstituted cholanoic acids in human feces.

Authors:  P Eneroth; B Gordon; J Sjövall
Journal:  J Lipid Res       Date:  1966-07       Impact factor: 5.922

10.  Metabolism of steroid and amino acid moieties of conjugated bile acids in man. II. Glycine-conjugated dihydroxy bile acids.

Authors:  G W Hepner; A F Hofmann; P J Thomas
Journal:  J Clin Invest       Date:  1972-07       Impact factor: 14.808

View more
  15 in total

Review 1.  Fetal and neonatal bile acid synthesis and metabolism--clinical implications.

Authors:  W F Balistreri
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

2.  Measurement of conjugated and unconjugated serum bile acid concentrations using 3 alpha-hydroxysteroid dehydrogenase.

Authors:  S M Smith; M Myszor; K D Setchell; G M Murphy
Journal:  J Clin Pathol       Date:  1983-02       Impact factor: 3.411

3.  Enzymatic determination of serum 3 alpha-sulfated bile acids concentration with bile acid 3 alpha-sulfate sulfohydrolase.

Authors:  T Kato; M Yoneda; K Nakamura; I Makino
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

Review 4.  Clinical pharmacokinetics of therapeutic bile acids.

Authors:  A Crosignani; K D Setchell; P Invernizzi; A Larghi; C M Rodrigues; M Podda
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

5.  Serum unconjugated bile acids as a test for intestinal bacterial overgrowth in dogs.

Authors:  T Melgarejo; D A Williams; N C O'Connell; K D Setchell
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

6.  Hepatic and extrahepatic glucuronidation of bile acids in man. Characterization of bile acid uridine 5'-diphosphate-glucuronosyltransferase in hepatic, renal, and intestinal microsomes.

Authors:  S Matern; H Matern; E H Farthmann; W Gerok
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

7.  Gall bladder emptying patterns in response to a normal meal in healthy subjects and patients with gall stones: ultrasound study.

Authors:  P J Howard; G M Murphy; R H Dowling
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

8.  Description and simulation of a physiological pharmacokinetic model for the metabolism and enterohepatic circulation of bile acids in man. Cholic acid in healthy man.

Authors:  A F Hofmann; G Molino; M Milanese; G Belforte
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

9.  Intestinal involvement in progressive systemic sclerosis detected by increased unconjugated serum bile acids.

Authors:  F Stellaard; T Sauerbruch; C H Luderschmidt; B Leisner; G Paumgartner
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

10.  Unconjugated secondary bile acids in the serum of patients with colorectal adenomas.

Authors:  E Bayerdörffer; G A Mannes; T Ochsenkühn; P Dirschedl; B Wiebecke; G Paumgartner
Journal:  Gut       Date:  1995-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.